Sumbele, Irene Ule Ngole https://orcid.org/0000-0003-2607-8845
Otia, Ofon Vitalis
Bopda, Orelien Sylvain Mtopi
Ebai, Calvin Bisong
Kimbi, Helen KuoKuo
Nkuo-Akenji, Theresa
Article History
Received: 1 September 2020
Accepted: 29 January 2021
First Online: 17 February 2021
Ethics approval and consent to participate
: The study protocol was reviewed and approved by the Institutional Ethical Review Board hosted by the Faculty of Health Sciences, University of Buea (2014/243/UB/FHS/IRB) after administrative clearance from the South West Regional Delegation of Public Health and Basic Education were obtained. The population was sensitized in the various communities at the beginning of the study. Written informed consent was obtained from all parents/caregivers whose child/children participated in the study after explaining the purpose and benefits of their participation. Participation was totally voluntary, and a participant could opt out of the study at any time without any penalty. Participants who had malaria and or helminths were given first line treatment as recommended by the national treatment guideline policy for malaria (artesunate-amodiaquine) and helminths (praziquantel for urogenital schistosomiasis and mebendazole of STH).
: Not applicable.
: The authors declare that they have no competing interests.